Skip to main content
. Author manuscript; available in PMC: 2017 Jan 11.
Published in final edited form as: J Nucl Med. 2015 Feb 19;56(4):616–621. doi: 10.2967/jnumed.114.149484

FIGURE 6.

FIGURE 6

(A) Representative coronal PET images of 64Cu-NOTA-tenascin-C aptamer and 64Cu-NOTA-Sc aptamer in different tumor models (tenascin-C–positive [U87MG and MDA-MB-435] and tenascin-C–negative [H460]) at 6 h after injection. White arrows represent tumor location. (B) Quantified results of tumor uptake of both tracers, calculated from PET images at 6 h after injection (n = 5/group). TsC = tenascin-C.